LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories (ABL), a Luxembourg-based biotech company, and developers of the TherapyEdge™-ViroScore™ platform, are pleased to announce a poster presentation at the 20th International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies held in Los Cabos (Mexico). Researchers reported, in the context of the PRIUS study, the use of the first complete clinical genotyping solution using high-throughput sequencing with the GS Flex System from 454 Life Sciences, a Roche Company, and an innovative downstream analysis and reporting software package, DeepChek™-HIV, from ABL. This integrated solution processes large HIV sequencing information, analyzes and generates clinically meaningful genotyping reports towards personalized patient management.
